Bain Capital Specialty Finance, Inc.
BCSFAnalytical Summary
Bain Capital Specialty Finance, Inc. faces fundamental challenges with weakness in Debt to Equity. The fundamentals warrant careful consideration of downside risks.
6-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Debt to EquityDebt to Equity is concerning (bottom quartile)
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|
| EPS Growth YoY (%) |
-17.3%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-3.1%
Weak
↓
Weak
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
17.2%
Good
↓
Good
Declining
Year-over-year change in earnings per share
Optimal:
> 10%
|
-12.4%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
1228.6%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
— |
| Net Income Growth YoY (%) |
-17.3%
Weak
↓
Weak
Declining
Year-over-year change in net income |
-3.2%
Weak
↓
Weak
Declining
Year-over-year change in net income |
17.0%
Good
↓
Good
Declining
Year-over-year change in net income |
-12.0%
Weak
Weak
Year-over-year change in net income |
1347.3%
Excellent
Excellent
Year-over-year change in net income |
— |
| FCF Growth YoY (%) | N/M | N/M | N/M | N/M |
169.9%
Excellent
Excellent
Year-over-year change in free cash flow |
— |
| EPS CAGR 3Y (%) |
-2.1%
Weak
↓
Weak
Declining
Compound annual EPS growth over 3 years |
-0.2%
Weak
Weak
Compound annual EPS growth over 3 years |
138.9%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
0.30x
Weak
↑
Weak
Improving
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.23x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
1.78x
Excellent
↓
Excellent
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-3.00x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
2.22x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
10.80x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
8.8%
Caution
↓
Caution
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
10.5%
Fair
→
Fair
Stable
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
10.9%
Fair
↑
Fair
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
9.4%
Caution
Caution
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
10.9%
Fair
Fair
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|
| Debt to Equity (x) |
1.32x
Caution
↑
Caution
Improving
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.22x
Caution
→
Caution
Stable
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.11x
Caution
↓
Caution
Declining
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.24x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
1.29x
Caution
Caution
Total debt relative to shareholder equity
Optimal:
< 0.6x
|
— |
| Net Debt (USD) | $1.45B | $1.34B | $1.21B | $1.36B | $1.33B | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ | FY 2021 Dec 31, 2021 10-K ↗ | FY 2020 Dec 31, 2020 10-K ↗ |
|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $98.76M | $119.42M | $123.38M | $105.48M | $119.81M | $8.28M |
| Operating Cash Flow (USD) | $29.52M | $-27.10M | $219.26M | $-316.83M | $265.55M | $89.42M |
Secondary lens
Benchmark Lens
Compare BCSF against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare BCSF against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for BCSF
No bullish signals detected
Debt to Equity is concerning (bottom quartile)
Percentile Rankings
How BCSF compares to all companies
Compare BCSF with peers
Stack BCSF against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 6 years · 20 quarters